Gene · 3313
Papers3,383
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,383
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enterovirus 71 non-structural protein 3A hijacks vacuolar protein sorting 25 to boost exosome biogenesis to facilitate viral replication. | Front Microbiol | 2022 | 36274707 | PubTator, text mining | PubMed |
| Proteome alterations during clonal isolation of established human pancreatic cancer cell lines. | Cell Mol Life Sci | 2022 | 36271971 | PubTator, text mining | PubMed |
| HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease. | Dis Markers | 2022 | 36246562 | PubTator, text mining | PubMed |
| USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. | Oncogene | 2022 | 36243803 | PubTator, text mining | PubMed |
| Psoriasis, Is It a Microdamage of Our "Sixth Sense"? A Neurocentric View. | Int J Mol Sci | 2022 | 36233237 | PubTator, text mining | PubMed |
| Mitochondrial VDAC1: A Potential Therapeutic Target of Inflammation-Related Diseases and Clinical Opportunities. | Cells | 2022 | 36231136 | PubTator, text mining | PubMed |
| Knockdown of TMEM160 leads to an increase in reactive oxygen species generation and the induction of the mitochondrial unfolded protein response. | FEBS Open Bio | 2022 | 36217717 | PubTator, text mining | PubMed |
| Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma. | Biol Direct | 2022 | 36209249 | PubTator, text mining | PubMed |
| Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2. | Front Oncol | 2022 | 36203464 | PubTator, text mining | PubMed |
| Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop. | Mol Cancer | 2022 | 36199071 | PubTator, text mining | PubMed |
| UPRmt and coordinated UPRER in type 2 diabetes. | Front Cell Dev Biol | 2022 | 36187475 | PubTator, text mining | PubMed |
| MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | Genome Biol | 2022 | 36180891 | PubTator, text mining | PubMed |
| Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks. | Redox Biol | 2022 | 36174386 | PubTator, text mining | PubMed |
| ER stress promotes mitochondrial DNA mediated type-1 interferon response in beta-cells and interleukin-8 driven neutrophil chemotaxis. | Front Endocrinol (Lausanne) | 2022 | 36171907 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Mitochondrial-Endoplasmic Reticulum Communication-Mediated Oxidative Stress and Autophagy. | Biomed Res Int | 2022 | 36164446 | PubTator, text mining | PubMed |
| Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis. | Toxicol Rep | 2022 | 36158865 | PubTator, text mining | PubMed |
| MFN2 mediates ER-mitochondrial coupling during ER stress through specialized stable contact sites. | Front Cell Dev Biol | 2022 | 36158213 | PubTator, text mining | PubMed |
| ER-mitochondria contact sites; a multifaceted factory for Ca2+ signaling and lipid transport. | Front Cell Dev Biol | 2022 | 36158205 | PubTator, text mining | PubMed |
| Disruption of mitochondria-associated ER membranes impairs insulin sensitivity and thermogenic function of adipocytes. | Front Cell Dev Biol | 2022 | 36158195 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3313/papers?page=29